Text Size

Treatment of Schizophrenia Through Internet-Based Psychoeducation

This study has been completed.
Sponsor:
Information provided by:
National Institute of Mental Health (NIMH)
ClinicalTrials.gov Identifier:
NCT00051233
First received: January 7, 2003
Last updated: November 17, 2005
Last verified: November 2005
History of Changes
  Purpose

The purpose of this study is to assess the effectiveness of a Web-based psychoeducational program in helping people with schizophrenia and their families manage the disease.


Condition Intervention Phase
Schizophrenia
Schizoaffective Disorder
 Procedure: World Wide Web-Based Psychoeducation
 Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Schizophrenia Patient and Family Continuity of Care

Resource links provided by NLM:

MedlinePlus related topics: Schizophrenia
U.S. FDA Resources

Further study details as provided by National Institute of Mental Health (NIMH):

Estimated Enrollment: 40
Study Start Date: January 2003
Estimated Study Completion Date: January 2005
Detailed Description:

This study will provide a comprehensive psychoeducational program which includes education, social support, information, coping strategies, and guidance from mental health, social services, and medical professionals. This study will work to reduce relapse, facilitate patient rehabilitation, decrease family distress, and improve family well being.

Patients and their families participate in an in-person Psychoeducational Survival Skills Workshop that is designed to provide patients and their families with basic information about schizophrenia and its treatment. After the workshop, participants are provided with 6 Web-based modules that are designed to increase mental health and schizophrenia knowledge. Patient relapse, family distress, family knowledge of schizophrenia, and data on user's acceptance and utilization are measured to determine the intervention's effectiveness.

  Eligibility

Ages Eligible for Study:   14 Years to 55 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria

  • DSM-IV diagnosis of schizophrenia or schizoaffective disorder
  • At least 4 hours/week in-person contact with a family member
  • Primary caregiver with a telephone
  • Patient and primary caregiver speak and read English

Exclusion Criteria:

  • Enrolled in another clinical trial
  • Evidence of organic brain syndrome
  • Current alcohol or substance abuse that could explain the presenting index psychotic episode
  • DSM-IV diagnosis of psychoactive substance dependency
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00051233

Locations
United States, Pennsylvania
University of Pittsburgh Western Psychiatric Institute and Clinic
Pittsburgh, Pennsylvania, United States, 15261
Sponsors and Collaborators
National Institute of Mental Health (NIMH)
Investigators
Principal Investigator: Armando J Rotondi University of Pittsburgh
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00051233     History of Changes
Other Study ID Numbers: R01 MH63484, DSIR SE-DR
Study First Received: January 7, 2003
Last Updated: November 17, 2005
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Psychotic Disorders
Schizophrenia
Schizophrenia and Disorders with Psychotic Features
Mental Disorders

ClinicalTrials.gov processed this record on May 23, 2013